STOCK TITAN

Twist Bioscience Corporation - TWST STOCK NEWS

Welcome to our dedicated page for Twist Bioscience Corporation news (Ticker: TWST), a resource for investors and traders seeking the latest updates and insights on Twist Bioscience Corporation stock.

Twist Bioscience Corporation, symbol TWST, stands at the forefront of synthetic biology with an innovative approach to DNA synthesis. The company's core expertise lies in developing a proprietary semiconductor-based synthetic DNA manufacturing process. This process utilizes a unique 10,000-well silicon platform, markedly different from the traditional 96-well plastic plates. This advanced platform enables the production of synthetic biology tools, such as oligonucleotides, genes, pathways, chassis, and genomes, in a more efficient, cost-effective, and high-throughput manner.

The implications of Twist Bioscience's technology are profound, offering the potential to revolutionize various fields. By synthesizing DNA on silicon, the company overcomes existing production inefficiencies, ensuring rapid and high-quality DNA synthesis. This capability is crucial for accelerating developments in personalized medicine, sustainable chemical production, agricultural improvements, in vivo diagnostics, biodetection, and even data storage.

Based primarily in the United States, Twist Bioscience derives the majority of its revenue from its home market. The company's strategic partnerships and ongoing projects reflect its commitment to pioneering advancements in synthetic biology. Having positioned itself as a leader in the field, Twist Bioscience continues to support researchers and industries by providing high-quality synthetic DNA rapidly, enabling them to seize emerging opportunities.

For more information, please visit Twist Bioscience.

Rhea-AI Summary
Twist Bioscience Corporation (NASDAQ: TWST) announced that Patrick Finn, Ph.D., will participate in the UBS MedTech, Tools and Genomics Summit 2023 panel on August 15. The panel will discuss Innovation Across Drug Discovery, Molecule Synthesis, & Precision Medicine. The event will be webcast live and available for replay on the company's investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.35%
Tags
conferences
-
Rhea-AI Summary
Twist Bioscience reports record revenue of $63.7M in 3QFY23, a 14% increase over last year. Orders also increased by 7% to $63.8M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.18%
Tags
-
Rhea-AI Summary
Twist Bioscience Corporation (NASDAQ: TWST) to release fiscal 2023 third quarter financial results on August 4, 2023, with a conference call and live webcast for analysts and investors to discuss the results and business update.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
conferences earnings
Rhea-AI Summary
Twist Bioscience Corporation (NASDAQ: TWST) and Cancer Research Horizons, the innovation arm of Cancer Research UK, have announced an agreement where Cancer Research Horizons will license the entire Twist Biopharma Solutions Library of Libraries. This collaboration aims to enhance antibody discovery capabilities to accelerate the delivery of high-quality therapeutics and diagnostics to cancer patients. Twist will receive a library access fee and will be eligible to receive annual maintenance fees as well as a share of revenue from any assets sold or transferred.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.76%
Tags
none
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.38%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.26%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.56%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
management
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.58%
Tags
none

FAQ

What is the current stock price of Twist Bioscience Corporation (TWST)?

The current stock price of Twist Bioscience Corporation (TWST) is $41.66 as of November 21, 2024.

What is the market cap of Twist Bioscience Corporation (TWST)?

The market cap of Twist Bioscience Corporation (TWST) is approximately 2.4B.

What does Twist Bioscience Corporation do?

Twist Bioscience specializes in synthetic DNA production, utilizing a proprietary semiconductor-based platform to create high-quality DNA efficiently.

How does Twist Bioscience's technology differ from traditional methods?

Twist Bioscience uses a 10,000-well silicon platform instead of traditional 96-well plastic plates, offering faster, cost-effective, and high-throughput DNA synthesis.

What are some applications of Twist Bioscience's synthetic DNA?

Applications include personalized medicine, sustainable chemical production, improved agriculture, in vivo diagnostics, biodetection, and data storage.

Where does Twist Bioscience generate most of its revenue?

Twist Bioscience primarily generates its revenue from the United States.

How does Twist Bioscience contribute to personalized medicine?

By providing rapid and high-quality DNA synthesis, Twist Bioscience accelerates the development of personalized medical treatments.

What is the significance of using silicon in DNA synthesis?

Using silicon allows Twist Bioscience to overcome inefficiencies in traditional DNA production, enabling faster and more cost-effective synthesis.

Can Twist Bioscience's technology be used in agriculture?

Yes, the synthetic DNA tools can improve agricultural production by enabling the development of better crops and agricultural methods.

What ongoing projects does Twist Bioscience have?

Twist Bioscience is involved in various projects across personalized medicine, sustainable chemical production, and new applications such as in vivo diagnostics and data storage.

How does Twist Bioscience's platform support researchers?

The platform provides researchers with high-throughput, high-quality synthetic DNA, enabling them to quickly explore and develop new opportunities.

Where can I find more information about Twist Bioscience?

Additional information is available on their official website: www.twistbioscience.com.

Twist Bioscience Corporation

Nasdaq:TWST

TWST Rankings

TWST Stock Data

2.41B
58.13M
1.94%
110.12%
15.4%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States of America
SOUTH SAN FRANCISCO